Filing Overview
Cencora, Inc. filed a Form 8-K under Item 5.02 on September 24, 2026, reporting the appointment of Robert E. Sanchez to its Board of Directors, effective October 1, 2026. The report was signed on September 25, 2026.
Business Context and Reporting Period
The filing concerns a corporate governance change rather than quarterly or annual financial results. Cencora is incorporated in Delaware and is headquartered in Conshohocken, Pennsylvania. Its common stock and certain senior notes trade on the New York Stock Exchange.
Financial and Liquidity Information
The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics. No financial statements or financial guidance are included.
Material Changes and Governance
- Robert E. Sanchez was appointed to the Board effective October 1, 2026.
- The Board expanded from ten to eleven members under the Company’s amended and restated bylaws.
- Mr. Sanchez will receive the same compensation and benefits as other non-employee directors under the Company’s director compensation policy.
- His annual equity award will be prorated from the effective date through the 2027 Annual Meeting of Stockholders, and cash compensation will be paid quarterly.
- Mr. Sanchez has not been assigned to a Board committee as of the filing date.
Management Commentary, Risks, and Unusual Items
The filing states that there are no arrangements or understandings with other persons related to Mr. Sanchez’s appointment, no family relationships with Company directors or executive officers, and no related-party transactions requiring disclosure under Item 404(a) of Regulation S-K.
The Company issued a September 25, 2026 news release announcing the appointment. The related Item 7.01 information and Exhibit 99.1 were furnished, not filed, and are generally not subject to Section 18 liability or incorporated by reference unless expressly stated.
Investor Verification Items
- Verify Mr. Sanchez’s background and expected contribution to Board oversight.
- Review the Company’s Compensation Policy for Non-Employee Directors and the prorated equity award terms.
- Confirm Board committee assignments and composition after the October 1, 2026 effective date.
- Review Exhibit 99.1, the September 25, 2026 press release, for additional appointment details.
- Consult subsequent filings for any changes to Board composition, committee membership, or director compensation.